Chris Komelasky is the CEO and Co-founder of SiteBridge Research. Chris has extensive experience as a management consultant and healthcare executive in the areas of strategy, operations, data analytics, commercialization, and business transformation in Pharmaceutical and CRO organizations.
Chris was previously the Executive Director of PPD’s Site and Patient Access group driving the innovation agenda and a portfolio of strategic initiatives helping to enable a move towards more data-driven decision making, where he also led the Global Investigator Services and Strategic Site Collaboration teams. Prior to joining PPD, was at GSK in global strategy, business transformation and commercialization and in management and strategy consulting at Accenture and ZS Associates.
Chris holds a B.S. in Systems Engineering from the University of Virginia and an MBA from Duke University’s the Fuqua School of Business and resides with his wife and three children in Chapel Hill, NC.